The company officially commenced production in 2018, with cumulative investments exceeding 100 million RMB. Its comprehensive product portfolio includes disposable infusion sets, syringes, medicine dispensers, drainage bags, and other sterile medical consumables, with an impressive annual production capacity of 300 million units across various product lines.
Zhejiang Renxiang has established a robust quality management system in full compliance with ISO 13485:2016 (GB/T42061-2022), the international standard for medical device quality management. The company operates with a structured organizational framework consisting of seven departments: General Manager's Office, Administration, Technology, Supply and Marketing, Production, Quality Management, and Finance. With a dedicated team of 120 employees, including 30 management personnel and 7 professional technical R&D professionals, Renxiang maintains a strong focus on quality, innovation, and operational excellence.
In alignment with its strategic development goals, since 2023, the company has successfully completed domestic registration for 8 products and EU registration for 5 products under its own brand. Its products are primarily exported to high-end consumable markets in Europe, the United States, Russia, the Middle East, and Africa. The company has also established in-depth cooperation with listed companies such as Anhui Hongyu Wuzhou and Zhejiang Kangdelai, and has been designated as the preferred OEM manufacturing partner by multiple collaborators.
Renxiang's products feature medical-grade polymer materials that are transparent, soft, and biocompatible. Each device is individually packaged and sterilized with ethylene oxide, ensuring sterility, non-pyrogenicity, and non-hemolytic properties. The single-use design effectively prevents cross-infection and meets clinical infection control requirements. Precision flow control mechanisms and integrated drug filters enhance infusion safety and accuracy.
Zhejiang Renxiang Medical Devices Co., Ltd. remains steadfast in its commitment to advancing global healthcare through the provision of safe, reliable, and cost-effective sterile medical products.